Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Management Information Circular

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon May 29, 2024 11:48am

181 Views

Post# 36062452

RE:RE:RE:RE:Management Information Circular

You might make a good point. An external party could request they get a different auditing firm and have the financials re-reviewed or who knows what. Prior to something big happening. But 3x in 5 years? Has the company changed that much in the past 5 years?

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale